LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Funding NGM Biopharmaceuticals recently secured $122M in Series A funding, indicating a strong financial position and potential for significant growth. This infusion of capital can be leveraged as a sales opportunity to expand operations and drive new business initiatives.

Clinical Trial Launches NGM Bio has launched clinical trials for promising drugs like aldafermin, demonstrating a commitment to developing innovative treatments. Sales development representatives can capitalize on these milestones to engage with healthcare providers and institutions interested in cutting-edge therapies.

Strategic Acquisitions Following an acquisition by The Column Group, NGM Bio has evolved its strategic focus. Sales teams can explore partnership opportunities resulting from this acquisition to offer collaborative solutions and enhance their market presence.

Expert Additions NGM Biopharmaceuticals has appointed key personnel like Mr. Svennilson to its Board of Directors, bringing valuable expertise to the leadership team. Sales professionals can utilize these connections to build relationships with industry experts and leverage their networks for business growth.

Innovative Pipeline With a pipeline of novel therapeutic candidates developed in-house, NGM Bio showcases a commitment to innovation. Sales teams can highlight these unique offerings to healthcare providers, demonstrating the company's competitive edge and potential value for patients.

Similar companies to NGM Biopharmaceuticals

NGM Biopharmaceuticals Tech Stack

NGM Biopharmaceuticals uses 8 technology products and services including QuickBooks, LinkedIn Recruiter, jQuery CDN, and more. Explore NGM Biopharmaceuticals's tech stack below.

  • QuickBooks
    Accounting And Finance
  • LinkedIn Recruiter
    Applicant Tracking Systems
  • jQuery CDN
    Content Delivery Network
  • Shopify
    E-commerce
  • Google Workspace
    Email
  • HSTS
    Security
  • Adobe Creative Suite
    Visualisation Software
  • Twitter
    Widgets

Media & News

NGM Biopharmaceuticals's Email Address Formats

NGM Biopharmaceuticals uses at least 1 format(s):
NGM Biopharmaceuticals Email FormatsExamplePercentage
FLast@ngmbio.comJDoe@ngmbio.com
88%
First.Last@ngmbio.comJohn.Doe@ngmbio.com
10%
Last@ngmbio.comDoe@ngmbio.com
1%
LastF@ngmbio.comDoeJ@ngmbio.com
1%

Frequently Asked Questions

Where is NGM Biopharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals's main headquarters is located at 333 Oyster Point Blvd. South San Francisco, CA 94080 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is NGM Biopharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact NGM Biopharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NGM Biopharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals is a publicly traded company; the company's stock symbol is NGM.

What is NGM Biopharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals's official website is ngmbio.com and has social profiles on LinkedIn.

How much revenue does NGM Biopharmaceuticals generate?

Minus sign iconPlus sign icon
As of September 2024, NGM Biopharmaceuticals's annual revenue reached $35M.

What is NGM Biopharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NGM Biopharmaceuticals have currently?

Minus sign iconPlus sign icon
As of September 2024, NGM Biopharmaceuticals has approximately 164 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: D. W.Chief Executive Officer: W. R.Chief Financial Officer: J. V.. Explore NGM Biopharmaceuticals's employee directory with LeadIQ.

What industry does NGM Biopharmaceuticals belong to?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals operates in the Biotechnology Research industry.

What technology does NGM Biopharmaceuticals use?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals's tech stack includes QuickBooksLinkedIn RecruiterjQuery CDNShopifyGoogle WorkspaceHSTSAdobe Creative SuiteTwitter.

What is NGM Biopharmaceuticals's email format?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals's email format typically follows the pattern of . Find more NGM Biopharmaceuticals email formats with LeadIQ.

How much funding has NGM Biopharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of September 2024, NGM Biopharmaceuticals has raised $122M in funding. The last funding round occurred on Jul 17, 2024 for $122M.

When was NGM Biopharmaceuticals founded?

Minus sign iconPlus sign icon
NGM Biopharmaceuticals was founded in 2008.
NGM Biopharmaceuticals

NGM Biopharmaceuticals

Biotechnology ResearchCalifornia, United States51-200 Employees

NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the frontier of life-changing science, NGM Bio aspires to operate one of the most productive research and development engines in the biopharmaceutical industry. All therapeutic candidates in the NGM Bio pipeline have been generated by its in-house discovery engine, always led by biology and motivated by unmet patient need. In addition to a healthy balance sheet and cash runway, the company currently has four programs in active clinical development. Visit us at www.ngmbio.com for more information.

Section iconCompany Overview

Headquarters
333 Oyster Point Blvd. South San Francisco, CA 94080 US
Phone number
Website
ngmbio.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NGM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $122M

    NGM Biopharmaceuticals has raised a total of $122M of funding over 7 rounds. Their latest funding round was raised on Jul 17, 2024 in the amount of $122M.

  • $10M$50M

    NGM Biopharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $122M

    NGM Biopharmaceuticals has raised a total of $122M of funding over 7 rounds. Their latest funding round was raised on Jul 17, 2024 in the amount of $122M.

  • $10M$50M

    NGM Biopharmaceuticals's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.